Entity Details

Primary name FLNC_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ14315
EntryNameFLNC_HUMAN
FullNameFilamin-C
TaxID9606
Evidenceevidence at protein level
Length2725
SequenceStatuscomplete
DateCreated2003-06-16
DateModified2021-06-02

Ontological Relatives

GenesFLNC

GO terms

Show/Hide Table
GOName
GO:0003779 actin binding
GO:0005737 cytoplasm
GO:0005829 cytosol
GO:0005856 cytoskeleton
GO:0005886 plasma membrane
GO:0005925 focal adhesion
GO:0008092 cytoskeletal protein binding
GO:0016528 sarcoplasm
GO:0030018 Z disc
GO:0030506 ankyrin binding
GO:0034329 cell junction assembly
GO:0042383 sarcolemma
GO:0042802 identical protein binding
GO:0043034 costamere

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001298 Filamin/ABP280 repeatRepeatRepeat
IPR001589 Actinin-type actin-binding domain, conserved siteSiteConserved site
IPR001715 Calponin homology domainDomainDomain
IPR013783 Immunoglobulin-like foldFamilyHomologous superfamily
IPR014756 Immunoglobulin E-setFamilyHomologous superfamily
IPR017868 Filamin/ABP280 repeat-likeRepeatRepeat
IPR036872 CH domain superfamilyFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
617047 OMIMCardiomyopathy, familial hypertrophic 26 (CMH26)A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. The disease is caused by variants affecting the gene represented in this entry.
617047 OMIMCardiomyopathy, familial hypertrophic 26 (CMH26)A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. The disease is caused by variants affecting the gene represented in this entry.
609524 OMIMMyopathy, myofibrillar, 5 (MFM5)A form of myofibrillar myopathy, a group of chronic neuromuscular disorders characterized at ultrastructural level by disintegration of the sarcomeric Z disk and myofibrils, and replacement of the normal myofibrillar markings by small dense granules, or larger hyaline masses, or amorphous material. MFM5 is characterized by onset in adulthood, clinical features of a limb-girdle myopathy, and focal myofibrillar destruction. The disease is caused by variants affecting the gene represented in this entry.
614065 OMIMMyopathy, distal, 4 (MPD4)A slowly progressive muscular disorder characterized by distal muscle weakness and atrophy affecting the upper and lower limbs. Onset occurs around the third to fourth decades of life, and patients remain ambulatory even after long disease duration. Muscle biopsy shows non-specific changes with no evidence of rods, necrosis, or inflammation. The disease is caused by variants affecting the gene represented in this entry.

Interactions

54 interactions

InteractorPartnerSourcesPublicationsLink
FLNC_HUMANSGCD_HUMANBioGRID, HPRD, MINT10629222 14506720 details
FLNC_HUMANSGCG_HUMANBioGRID, HPRD, MINT10629222 14506720 details
FLNC_HUMANMYOZ1_HUMANBioGRID, HPRD, MINT10984498 11171996 11842093 details
FLNC_HUMANADA1A_HUMANHPRD, IntAct15525470 details
FLNC_HUMANADA1D_HUMANHPRD, IntAct15525470 details
FLNC_HUMANADA1B_HUMANHPRD, IntAct15525470 details
FLNC_HUMANMYOTI_HUMANBioGRID, HPRD, IntAct11038172 details
FLNC_HUMANABL1_HUMANIntAct17474147 details
FLNC_HUMANCRK_HUMANIntAct17474147 details
FLNC_HUMANFYN_HUMANIntAct17474147 details
FLNC_HUMANGRB2_HUMANIntAct17474147 details
FLNC_HUMANNCK1_HUMANIntAct17474147 details
FLNC_HUMANP85A_HUMANIntAct17474147 details
FLNC_HUMANPLCG1_HUMANIntAct17474147 details
FLNC_HUMANTRI63_HUMANBioGRID, MINT18157088 details
FLNC_HUMANSMUF2_HUMANMINT18157088 details
FLNC_HUMANMLH1_HUMANIntAct20706999 details
FLNC_HUMANKS6A2_HUMANBioGRID, IntAct21988832 details
FLNC_HUMANDYSF_HUMANBioGRID, IntAct23414517 details
FLNC_HUMANENOA_HUMANBioGRID, IntAct22939629 23414517 details
FLNC_HUMANMYPC2_HUMANBioGRID, IntAct23414517 details
FLNC_HUMANREPS1_HUMANBioGRID, IntAct23414517 details
FLNC_HUMANXIRP1_HUMANBioGRID, IntAct16631741 23115302 details
FLNC_HUMANANK3_HUMANbhf-ucl, BioGRID21223964 details
FLNC_HUMANSYNEM_HUMANMINT25447537 details
FLNC_HUMANMYPC3_HUMANIntAct21569246 details
FLNC_HUMANHSPB2_HUMANbhf-ucl, BioGRID26465331 details
FLNC_HUMANFLNC_HUMANDIP15642266 details
FLNC_HUMANMP2K4_HUMANBioGRID, HPRD9006895 details
FLNC_HUMANCAN3_HUMANBioGRID, HPRD14506720 details
FLNC_HUMANKCND2_HUMANBioGRID, HPRD11102480 details
FLNC_HUMANPHLB2_HUMANBioGRID, HPRD12376540 details
FLNC_HUMANSHIP2_HUMANBioGRID, HPRD11739414 details
FLNC_HUMANUBP25_HUMANBioGRID16501887 details
FLNC_HUMANWNK1_HUMANBioGRID20936779 details
FLNC_HUMANAAKB2_HUMANBioGRID19616115 details
FLNC_HUMANTRI54_HUMANBioGRID17360532 details
FLNC_HUMANFXL22_HUMANBioGRID22972877 details
FLNC_HUMANXIRP2_HUMANBioGRID23115302 details
FLNC_HUMANSYNP2_HUMANBioGRID20554076 details
FLNC_HUMANTRI55_HUMANBioGRID18157088 details
FLNC_HUMANCDC42_HUMANBioGRID31478661 details
FLNC_HUMANFURIN_HUMANHPRD9412467 details
FLNC_HUMANNPHP1_HUMANHPRD12006559 details
FLNC_HUMANKY_HUMANHPRD15385448 details
FLNC_HUMANKPCA_HUMANHPRD12704190 details
FLNC_HUMANHIPK3_HUMANHPRD15231748 details
FLNC_HUMANTFIP8_HUMANIntAct17353931 details
FLNC_HUMANUBC9_HUMANIntAct20936779 details
FLNC_HUMANPAX4_HUMANIntAct28514442 details
FLNC_HUMANMYOZ2_HUMANBioGRID, HPRD11842093 details
FLNC_HUMANMYOZ3_HUMANBioGRID, HPRD11842093 details
FLNC_HUMANATOH1_HUMANBioGRID27542412 details
FLNC_HUMANSIAH2_HUMANBioGRID30063986 details